Your browser doesn't support javascript.
loading
Impact of HIV-1 infection on the IGF-1 axis and angiogenic factors in pregnant Cameroonian women receiving antiretroviral therapy.
Esemu, Livo F; Yuosembom, Emile K; Fang, Rui; Rasay, Shayne; Fodjo, Barriere A Y; Nguasong, John T; Kidima, Winifrida; Ekali, Gabriel L; Chen, John J; Ndhlovu, Lishomwa; Bigoga, Jude D; Taylor, Diane W; Leke, Rose G F; Babakhanyan, Anna.
Afiliação
  • Esemu LF; The Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
  • Yuosembom EK; Department of Biochemistry, University of Yaoundé I, Yaoundé, Cameroon.
  • Fang R; Center for Medical Research, Institute of Medical Research and Medicinal Plant Study, Yaoundé, Cameroon.
  • Rasay S; The Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
  • Fodjo BAY; Biostatistics Core, Department of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America.
  • Nguasong JT; Department of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America.
  • Kidima W; The Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
  • Ekali GL; Department of Biochemistry, University of Yaoundé I, Yaoundé, Cameroon.
  • Chen JJ; The Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
  • Ndhlovu L; Department of Biochemistry, University of Yaoundé I, Yaoundé, Cameroon.
  • Bigoga JD; Department of Zoology, College of Natural and Applied Sciences, University of Dar es Salaam, Dar es Salaam, Tanzania.
  • Taylor DW; The Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
  • Leke RGF; Biostatistics Core, Department of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America.
  • Babakhanyan A; Department of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America.
PLoS One ; 14(5): e0215825, 2019.
Article em En | MEDLINE | ID: mdl-31042729
ABSTRACT
Although mother-to-child transmission of HIV has dramatically declined, the number of in utero HIV-exposed, uninfected infants is on the increase. HIV-exposed infants are at an increased risk of mortality, morbidity and slower early growth than their non-HIV exposed counterparts. Maternal HIV increases the risk of having preterm deliveries, intrauterine growth restriction and low birth weight babies. However, the mechanism underlying dysregulation of fetal growth in HIV-infected pregnant women is unknown. We sought to determine whether maternal HIV is associated with dysregulation of the insulin-like growth factor (IGF) axis, some angiogenic factors or other related biomarkers that regulate fetal growth. A total of 102 normotensive pregnant women were enrolled in a small cross-sectional study. Amongst these were thirty-one HIV-1 positive women receiving combination antiretroviral therapy (cART) (Mean age 30.0 ± 5.1 years; % on ART 83.9%; median plasma viral load 683 copies/ml; median CD4 count 350 cells/ul) and 71 HIV uninfected women (mean age 27.3 ± 5.8) recruited at delivery. A panel of biomarkers including IGF1 and IGF binding proteins (IGFBP1, IGFBP3), angiopoietins (ANG) 1 and 2, matrix metalloproteinases (MMP) 2 and 9, and galectin 13, was measured in plasma collected from the placental intervillous space. The levels of IGF1, IGFBP1, ANG1, ANG2, MMP2, MMP9 and Gal-13 were not affected by maternal HIV, even when adjusted for maternal factors in linear regression models (all p>0.05). It was observed that HIV-infection in pregnancy did not significantly affect key markers of the IGF axis and angiogenic factors. If anything, it did not affect women. These findings highlight the importance of the use of ART during pregnancy, which maintains factors necessary for fetal development closer to those of healthy women. However, decrease in IGF1 levels might be exacerbated in women con-infected with HIV and malaria.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Insulin-Like I / Infecções por HIV / Angiopoietinas / Antirretrovirais Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Africa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Camarões

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Insulin-Like I / Infecções por HIV / Angiopoietinas / Antirretrovirais Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Africa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Camarões